<?xml version="1.0" encoding="UTF-8"?>
<xmi:XMI xmlns:text="http:///de/fraunhofer/scai/bio/extraction/types/text.ecore" xmlns:container="http:///de/fraunhofer/scai/bio/extraction/types/text/documentelement/container.ecore" xmlns:tcas="http:///uima/tcas.ecore" xmlns:meta2="http:///de/fraunhofer/scai/bio/extraction/types/text/documentelement/meta.ecore" xmlns:xmi="http://www.omg.org/XMI" xmlns:cas="http:///uima/cas.ecore" xmlns:structure="http:///de/fraunhofer/scai/bio/extraction/types/text/documentelement/structure.ecore" xmlns:image="http:///de/fraunhofer/scai/bio/extraction/types/image.ecore" xmlns:provenance="http:///de/fraunhofer/scai/bio/extraction/types/meta/provenance.ecore" xmlns:meta="http:///de/fraunhofer/scai/bio/extraction/types/meta.ecore" xmlns:documentelement="http:///de/fraunhofer/scai/bio/extraction/types/text/documentelement.ecore" xmi:version="2.0">
    <cas:NULL xmi:id="0"/>
    <meta:Person xmi:id="1" surname="uimahpc"/>
    <meta:Person xmi:id="6" surname="uimahpc"/>
    <meta:Person xmi:id="11" surname="msood"/>
    <provenance:AgentProvenance xmi:id="16" user="1"/>
    <provenance:AgentProvenance xmi:id="18" user="6"/>
    <provenance:AgentProvenance xmi:id="20" user="11"/>
    <provenance:ActivityProvenance xmi:id="22" componentId="de.fraunhofer.scai.bio.uima.core.reader.XCasMessageReader" startedAtTime="1806" endedAtTime="1813" version="7.1-SNAPSHOT" parameters="147 151 155 159 163 167 171 1820" wasAssociatedWith="16"/>
    <provenance:ActivityProvenance xmi:id="39" componentId="de.fraunhofer.scai.bio.uima.core.reader.XCasMessageReader" startedAtTime="1824" endedAtTime="1831" version="7.1-SNAPSHOT" parameters="195 175 251 211 275 247 291 311" wasAssociatedWith="18"/>
    <provenance:ActivityProvenance xmi:id="56" componentId="de.fraunhofer.scai.bio.uima.mysqlreader.ctgov.reader.MySQLReader" startedAtTime="1838" endedAtTime="1845" version="7.1-SNAPSHOT" parameters="227 243 279 187 179 295 231 203 315 199 271 1852 1856 319" wasAssociatedWith="20"/>
    <provenance:ActivityProvenance xmi:id="79" componentId="de.fraunhofer.scai.bio.uima.core.writer.XCasMessageWriter" startedAtTime="1860" endedAtTime="1867" version="7.1-SNAPSHOT" parameters="223 207 303 283 255 263" wasAssociatedWith="20"/>
    <provenance:ActivityProvenance xmi:id="94" componentId="de.fraunhofer.scai.bio.uima.onlp.sentencedetector.annotator.OpenNLP_SentenceDetector" startedAtTime="1874" endedAtTime="1881" version="7.1-SNAPSHOT" parameters="183 219 235 299" wasAssociatedWith="18"/>
    <provenance:ActivityProvenance xmi:id="107" componentId="de.fraunhofer.scai.bio.uima.core.writer.XCasMessageWriter" startedAtTime="1888" endedAtTime="1895" version="7.1-SNAPSHOT" parameters="259 307 191 215 287 239" wasAssociatedWith="18"/>
    <provenance:ActivityProvenance xmi:id="122" componentId="de.fraunhofer.scai.bio.uima.documentdecomposer.annotator.DocumentDecomposerAnnotator" startedAtTime="1902" endedAtTime="1909" version="7.1-SNAPSHOT" parameters="323" wasAssociatedWith="16"/>
    <provenance:ActivityProvenance xmi:id="132" componentId="de.fraunhofer.scai.bio.uima.core.writer.XCasMessageWriter" startedAtTime="1916" endedAtTime="1923" version="7.1-SNAPSHOT" parameters="327 331 335 339 343 347" wasAssociatedWith="16"/>
    <meta:Parameter xmi:id="147" key="jmsBroker" value="" wasGeneratedBy="22"/>
    <meta:Parameter xmi:id="151" key="jmsIni" value="/home/uimahpc/microservices/etc/jms.ini" wasGeneratedBy="22"/>
    <meta:Parameter xmi:id="155" key="jmsQueue" value="/queue/DocumentDecomposer.patents" wasGeneratedBy="22"/>
    <meta:Parameter xmi:id="159" key="jmsTool" value="DocumentDecomposerDeployer (7.1-SNAPSHOT)" wasGeneratedBy="22"/>
    <meta:Parameter xmi:id="163" key="documentCollectionName" value="" wasGeneratedBy="22"/>
    <meta:Parameter xmi:id="167" key="license" value="" wasGeneratedBy="22"/>
    <meta:Parameter xmi:id="171" key="recipients" value="" wasGeneratedBy="22"/>
    <meta:Parameter xmi:id="175" key="jmsIni" value="/home/uimahpc/microservices/etc/jms.ini" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="179" key="Query" value="select * from ctgov_AlzheimerFinal where id = 1463384" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="183" key="language" value="en" wasGeneratedBy="94"/>
    <meta:Parameter xmi:id="187" key="QueryFile" value="etc/query" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="191" key="jmsTool" value="OpenNLP_SentenceDetectorDeployer (7.1-SNAPSHOT)" wasGeneratedBy="107"/>
    <meta:Parameter xmi:id="195" key="jmsBroker" value="" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="199" key="offset" value="0" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="203" key="username" value="root" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="207" key="jmsIni" value="etc/jms.ini" wasGeneratedBy="79"/>
    <meta:Parameter xmi:id="211" key="jmsTool" value="OpenNLP_SentenceDetectorDeployer (7.1-SNAPSHOT)" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="215" key="jmsSource" value="/queue/ONLPSentenceDetector.en" wasGeneratedBy="107"/>
    <meta:Parameter xmi:id="219" key="lineSeparation" value="false" wasGeneratedBy="94"/>
    <meta:Parameter xmi:id="223" key="jmsBroker" value="draco1" wasGeneratedBy="79"/>
    <meta:Parameter xmi:id="227" key="condition" value="false" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="231" key="password" value="Espe52" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="235" key="doAbbrevFilter" value="false" wasGeneratedBy="94"/>
    <meta:Parameter xmi:id="239" key="storeResult" value="" wasGeneratedBy="107"/>
    <meta:Parameter xmi:id="243" key="recipient" value="/queue/ONLPSentenceDetector.en,/queue/DocumentDecomposer.patents,/queue/interfacer.xmi.meemansa," wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="247" key="license" value="" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="251" key="jmsQueue" value="/queue/ONLPSentenceDetector.en" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="255" key="jmsBilling" value="creating XCAS" wasGeneratedBy="79"/>
    <meta:Parameter xmi:id="259" key="jmsBroker" value="" wasGeneratedBy="107"/>
    <meta:Parameter xmi:id="263" key="storeResult" value="" wasGeneratedBy="79"/>
    <meta:Parameter xmi:id="267" key="inputString" value="" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="271" key="documentCollectionName" value="MZ" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="275" key="documentCollectionName" value="" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="279" key="trackingNr" value="MDAzMGxvY2F0aW9uIHd3dy5zY2FpLmZyYXVuaG9mZXIuZGUvbXppbW1lcm1hbm4KMDAxY2lkZW50aWZpZXIgdGVzdCBsaWNlbnNlCjAwMjBjaWQgdGltZSA8IDIwNDItMDEtMDFUMDA6MDAKMDAyZnNpZ25hdHVyZSAJPOFDaQbvzzfyMuZOWHaYgFxTnpiSu3K6JZ1ys7Vp1go" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="283" key="jmsSource" value="/queue/dummy" wasGeneratedBy="79"/>
    <meta:Parameter xmi:id="287" key="jmsBilling" value="creating XCAS" wasGeneratedBy="107"/>
    <meta:Parameter xmi:id="291" key="recipients" value="" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="295" key="connection" value="jdbc:mysql://flux:30008/aetionomy" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="299" key="typeFilter" value="" wasGeneratedBy="94"/>
    <meta:Parameter xmi:id="303" key="jmsTool" value="MysqlReaderMessageDeployer (7.1-SNAPSHOT)" wasGeneratedBy="79"/>
    <meta:Parameter xmi:id="307" key="jmsIni" value="/home/uimahpc/microservices/etc/jms.ini" wasGeneratedBy="107"/>
    <meta:Parameter xmi:id="311" key="event" value="" wasGeneratedBy="39"/>
    <meta:Parameter xmi:id="315" key="limit" value="1" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="319" key="event" value="" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="323" key="sectionIniFile" value="/home/uimahpc/microservices/etc/sections-patents.ini" wasGeneratedBy="122"/>
    <meta:Parameter xmi:id="327" key="jmsBroker" value="" wasGeneratedBy="132"/>
    <meta:Parameter xmi:id="331" key="jmsIni" value="/home/uimahpc/microservices/etc/jms.ini" wasGeneratedBy="132"/>
    <meta:Parameter xmi:id="335" key="jmsTool" value="DocumentDecomposerDeployer (7.1-SNAPSHOT)" wasGeneratedBy="132"/>
    <meta:Parameter xmi:id="339" key="jmsSource" value="/queue/DocumentDecomposer.patents" wasGeneratedBy="132"/>
    <meta:Parameter xmi:id="343" key="jmsBilling" value="creating XCAS" wasGeneratedBy="132"/>
    <meta:Parameter xmi:id="347" key="storeResult" value="" wasGeneratedBy="132"/>
    <meta:KeyValue xmi:id="351" key="event" value="ExtractHeader ExtractFrontMatter"/>
    <meta:KeyValue xmi:id="355" key="license" value="MDAzMGxvY2F0aW9uIHd3dy5zY2FpLmZyYXVuaG9mZXIuZGUvbXppbW1lcm1hbm4KMDAxY2lkZW50aWZpZXIgdGVzdCBsaWNlbnNlCjAwMjBjaWQgdGltZSA8IDIwNDItMDEtMDFUMDA6MDAKMDAyZnNpZ25hdHVyZSAJPOFDaQbvzzfyMuZOWHaYgFxTnpiSu3K6JZ1ys7Vp1go"/>
    <meta:KeyValue xmi:id="359" key="entityProvenance.documentURI" value="file:/home/msood/workspace/TheInterfacer/NCT01463384"/>
    <meta:KeyValue xmi:id="363" key="tracking-nr" value="MZ"/>
    <meta:KeyValue xmi:id="367" key="unit" value="24 [DocElems],57 [Paragraphs]"/>
    <tcas:DocumentAnnotation xmi:id="371" sofa="1785" begin="0" end="10291" language="x-unspecified"/>
    <meta:Header xmi:id="376" sofa="1785" begin="0" end="0" source="Huntington Medical Research Institutes" title="Minocycline in Patients With Alzheimer's Disease" authors="1930" publicationDate="1935" ISSN="NCT01463384" documentConcept="1939"/>
    <provenance:EntityProvenance xmi:id="392" documentID="c89ebe96fe177e141df5e46dca0810058590767c00bca0f849f38dc1db8d5c67" userSuppliedID="NCT01463384" wasDerivedFrom="http://www.scai.fraunhofer.de" workflowProvenance="56 79 39 94 107 22 122 132" wasGeneratedBy="56" wasAttributedTo="20" documentCollectionName="MZ"/>
    <tcas:DocumentAnnotation xmi:id="411" sofa="1792" begin="0" end="10291" language="x-unspecified"/>
    <meta2:DocumentTitle xmi:id="416" sofa="1792" begin="90" end="178" wasGeneratedBy="56"/>
    <meta2:Abstract xmi:id="424" sofa="1792" begin="696" end="1274" wasGeneratedBy="56"/>
    <container:Section xmi:id="430" sofa="1792" begin="0" end="681" wasGeneratedBy="56" title="Overview:" rhetorical="Overview:"/>
    <container:Section xmi:id="439" sofa="1792" begin="681" end="1276" wasGeneratedBy="56" title="Brief Summary:" rhetorical="Brief Summary:"/>
    <container:Section xmi:id="448" sofa="1792" begin="1276" end="3275" wasGeneratedBy="56" title="Detailed Description:" rhetorical="Detailed Description:"/>
    <container:Section xmi:id="457" sofa="1792" begin="3275" end="4089" wasGeneratedBy="56" title="Criteria:" rhetorical="Criteria:"/>
    <container:Section xmi:id="466" sofa="1792" begin="4089" end="4399" wasGeneratedBy="56" title="Further Study Details:" rhetorical="Further Study Details:"/>
    <container:Section xmi:id="475" sofa="1792" begin="4399" end="4668" wasGeneratedBy="56" title="Design Information:" rhetorical="Design Information:"/>
    <container:Section xmi:id="484" sofa="1792" begin="4668" end="4809" wasGeneratedBy="56" title="Intervention Information:" rhetorical="Intervention Information:"/>
    <container:Section xmi:id="493" sofa="1792" begin="4809" end="7649" wasGeneratedBy="56" title="Outcome Information:" rhetorical="Outcome Information:"/>
    <container:Section xmi:id="502" sofa="1792" begin="7649" end="7692" wasGeneratedBy="56" title="Outcome Analysis Details:" rhetorical="Outcome Analysis Details:"/>
    <container:Section xmi:id="511" sofa="1792" begin="7692" end="7949" wasGeneratedBy="56" title="Outcome Measure Details:" rhetorical="Outcome Measure Details:"/>
    <container:Section xmi:id="520" sofa="1792" begin="7949" end="8135" wasGeneratedBy="56" title="Outcome Values:" rhetorical="Outcome Values:"/>
    <container:Section xmi:id="529" sofa="1792" begin="8135" end="8657" wasGeneratedBy="56" title="Study Outcome Details:" rhetorical="Study Outcome Details:"/>
    <container:Section xmi:id="538" sofa="1792" begin="8657" end="8829" wasGeneratedBy="56" title="Location Details:" rhetorical="Location Details:"/>
    <container:Section xmi:id="547" sofa="1792" begin="8829" end="9802" wasGeneratedBy="56" title="Arm Group Details:" rhetorical="Arm Group Details:"/>
    <container:Section xmi:id="556" sofa="1792" begin="9802" end="10246" wasGeneratedBy="56" title="Baseline Information:" rhetorical="Baseline Information:"/>
    <container:SubSection xmi:id="565" sofa="1792" begin="1275" end="10291" wasGeneratedBy="122" title="DETAILS"/>
    <container:SubSection xmi:id="574" sofa="1792" begin="3285" end="3486" wasGeneratedBy="56" title="Inclusion Criteria." rhetorical="Inclusion Criteria."/>
    <container:SubSection xmi:id="583" sofa="1792" begin="3486" end="4089" wasGeneratedBy="56" title="Exclusion Criteria." rhetorical="Exclusion Criteria."/>
    <container:SubSection xmi:id="592" sofa="1792" begin="4830" end="7649" wasGeneratedBy="56" title="Outcome Details:" rhetorical="Outcome Details:"/>
    <container:SubSection xmi:id="601" sofa="1792" begin="8675" end="8786" wasGeneratedBy="56" title="Facility Details:" rhetorical="Facility Details:"/>
    <container:SubSection xmi:id="610" sofa="1792" begin="8786" end="8829" wasGeneratedBy="56" title="Facility Contact Details:" rhetorical="Facility Contact Details:"/>
    <container:SubSection xmi:id="619" sofa="1792" begin="9824" end="9844" wasGeneratedBy="56" title="Baseline ID:" rhetorical="Baseline ID:"/>
    <container:SubSection xmi:id="628" sofa="1792" begin="9844" end="9886" wasGeneratedBy="56" title="Baseline Measure Details:" rhetorical="Baseline Measure Details:"/>
    <container:SubSection xmi:id="637" sofa="1792" begin="9886" end="10246" wasGeneratedBy="56" title="Baseline Measure Cateogary Details:" rhetorical="Baseline Measure Cateogary Details:"/>
    <meta2:Reference xmi:id="646" sofa="1792" begin="4333" end="4347" wasGeneratedBy="56"/>
    <text:Sentence xmi:id="657" sofa="1792" begin="0" end="73" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="664" sofa="1792" begin="74" end="179" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="671" sofa="1792" begin="180" end="200" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="678" sofa="1792" begin="201" end="228" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="685" sofa="1792" begin="229" end="259" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="692" sofa="1792" begin="260" end="298" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="699" sofa="1792" begin="299" end="332" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="706" sofa="1792" begin="333" end="367" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="713" sofa="1792" begin="368" end="421" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="720" sofa="1792" begin="422" end="480" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="727" sofa="1792" begin="481" end="679" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="734" sofa="1792" begin="681" end="1008" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="741" sofa="1792" begin="1009" end="1162" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="748" sofa="1792" begin="1163" end="1274" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="755" sofa="1792" begin="1276" end="1755" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="762" sofa="1792" begin="1756" end="2078" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="769" sofa="1792" begin="2079" end="2242" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="776" sofa="1792" begin="2243" end="2447" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="783" sofa="1792" begin="2448" end="2562" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="790" sofa="1792" begin="2563" end="2683" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="797" sofa="1792" begin="2684" end="2850" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="804" sofa="1792" begin="2851" end="3024" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="811" sofa="1792" begin="3025" end="3273" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="818" sofa="1792" begin="3275" end="3304" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="825" sofa="1792" begin="3306" end="3485" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="832" sofa="1792" begin="3486" end="3505" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="839" sofa="1792" begin="3507" end="3649" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="846" sofa="1792" begin="3651" end="3789" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="853" sofa="1792" begin="3791" end="4087" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="860" sofa="1792" begin="4089" end="4138" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="867" sofa="1792" begin="4139" end="4182" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="874" sofa="1792" begin="4183" end="4229" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="881" sofa="1792" begin="4230" end="4245" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="888" sofa="1792" begin="4246" end="4259" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="895" sofa="1792" begin="4260" end="4282" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="902" sofa="1792" begin="4283" end="4305" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="909" sofa="1792" begin="4307" end="4371" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="916" sofa="1792" begin="4372" end="4397" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="923" sofa="1792" begin="4399" end="4488" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="930" sofa="1792" begin="4489" end="4561" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="937" sofa="1792" begin="4562" end="4610" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="944" sofa="1792" begin="4611" end="4665" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="951" sofa="1792" begin="4668" end="4807" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="958" sofa="1792" begin="4809" end="4870" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="965" sofa="1792" begin="4871" end="4961" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="972" sofa="1792" begin="4962" end="5050" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="979" sofa="1792" begin="5051" end="5224" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="986" sofa="1792" begin="5225" end="5469" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="993" sofa="1792" begin="5470" end="5500" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1000" sofa="1792" begin="5501" end="5948" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1007" sofa="1792" begin="5951" end="5973" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1014" sofa="1792" begin="5974" end="6219" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1021" sofa="1792" begin="6220" end="6336" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1028" sofa="1792" begin="6337" end="6416" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1035" sofa="1792" begin="6417" end="6544" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1042" sofa="1792" begin="6547" end="6569" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1049" sofa="1792" begin="6570" end="6722" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1056" sofa="1792" begin="6723" end="6811" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1063" sofa="1792" begin="6812" end="6997" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1070" sofa="1792" begin="6998" end="7160" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1077" sofa="1792" begin="7161" end="7372" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1084" sofa="1792" begin="7373" end="7461" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1091" sofa="1792" begin="7462" end="7524" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1098" sofa="1792" begin="7525" end="7652" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1105" sofa="1792" begin="7655" end="7697" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1112" sofa="1792" begin="7698" end="7776" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1119" sofa="1792" begin="7777" end="7828" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1126" sofa="1792" begin="7829" end="7892" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1133" sofa="1792" begin="7893" end="7953" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1140" sofa="1792" begin="7955" end="8020" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1147" sofa="1792" begin="8021" end="8139" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1154" sofa="1792" begin="8141" end="8287" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1161" sofa="1792" begin="8288" end="8476" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1168" sofa="1792" begin="8477" end="8660" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1175" sofa="1792" begin="8663" end="8791" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1182" sofa="1792" begin="8792" end="8833" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1189" sofa="1792" begin="8835" end="9003" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1196" sofa="1792" begin="9004" end="9147" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1203" sofa="1792" begin="9148" end="9304" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1210" sofa="1792" begin="9305" end="9480" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1217" sofa="1792" begin="9481" end="9641" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1224" sofa="1792" begin="9642" end="9805" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1231" sofa="1792" begin="9808" end="9849" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1238" sofa="1792" begin="9850" end="9891" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1245" sofa="1792" begin="9892" end="9974" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1252" sofa="1792" begin="9975" end="10019" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1259" sofa="1792" begin="10020" end="10066" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1266" sofa="1792" begin="10067" end="10111" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1273" sofa="1792" begin="10112" end="10158" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1280" sofa="1792" begin="10159" end="10205" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1287" sofa="1792" begin="10206" end="10249" wasGeneratedBy="94"/>
    <text:Sentence xmi:id="1294" sofa="1792" begin="10252" end="10291" wasGeneratedBy="94"/>
    <structure:Paragraph xmi:id="1301" sofa="1792" begin="4372" end="4397" wasGeneratedBy="122" rhetorical="par_1"/>
    <structure:Paragraph xmi:id="1308" sofa="1792" begin="4399" end="4418" wasGeneratedBy="122" rhetorical="par_2"/>
    <structure:Paragraph xmi:id="1315" sofa="1792" begin="4419" end="4488" wasGeneratedBy="122" rhetorical="par_3"/>
    <structure:Paragraph xmi:id="1322" sofa="1792" begin="4489" end="4561" wasGeneratedBy="122" rhetorical="par_4"/>
    <structure:Paragraph xmi:id="1329" sofa="1792" begin="4562" end="4610" wasGeneratedBy="122" rhetorical="par_5"/>
    <structure:Paragraph xmi:id="1336" sofa="1792" begin="4611" end="4665" wasGeneratedBy="122" rhetorical="par_6"/>
    <structure:Paragraph xmi:id="1343" sofa="1792" begin="4668" end="4693" wasGeneratedBy="122" rhetorical="par_7"/>
    <structure:Paragraph xmi:id="1350" sofa="1792" begin="4694" end="4807" wasGeneratedBy="122" rhetorical="par_8"/>
    <structure:Paragraph xmi:id="1357" sofa="1792" begin="4809" end="4829" wasGeneratedBy="122" rhetorical="par_9"/>
    <structure:Paragraph xmi:id="1364" sofa="1792" begin="4830" end="4846" wasGeneratedBy="122" rhetorical="par_10"/>
    <structure:Paragraph xmi:id="1371" sofa="1792" begin="4847" end="4870" wasGeneratedBy="122" rhetorical="par_11"/>
    <structure:Paragraph xmi:id="1378" sofa="1792" begin="4871" end="4961" wasGeneratedBy="122" rhetorical="par_12"/>
    <structure:Paragraph xmi:id="1385" sofa="1792" begin="4962" end="5050" wasGeneratedBy="122" rhetorical="par_13"/>
    <structure:Paragraph xmi:id="1392" sofa="1792" begin="5051" end="5949" wasGeneratedBy="122" rhetorical="par_14"/>
    <structure:Paragraph xmi:id="1399" sofa="1792" begin="5951" end="5973" wasGeneratedBy="122" rhetorical="par_15"/>
    <structure:Paragraph xmi:id="1406" sofa="1792" begin="5974" end="6130" wasGeneratedBy="122" rhetorical="par_16"/>
    <structure:Paragraph xmi:id="1413" sofa="1792" begin="6131" end="6219" wasGeneratedBy="122" rhetorical="par_17"/>
    <structure:Paragraph xmi:id="1420" sofa="1792" begin="6220" end="6545" wasGeneratedBy="122" rhetorical="par_18"/>
    <structure:Paragraph xmi:id="1427" sofa="1792" begin="6547" end="6569" wasGeneratedBy="122" rhetorical="par_19"/>
    <structure:Paragraph xmi:id="1434" sofa="1792" begin="6570" end="6722" wasGeneratedBy="122" rhetorical="par_20"/>
    <structure:Paragraph xmi:id="1441" sofa="1792" begin="6723" end="6811" wasGeneratedBy="122" rhetorical="par_21"/>
    <structure:Paragraph xmi:id="1448" sofa="1792" begin="6812" end="7652" wasGeneratedBy="122" rhetorical="par_22"/>
    <structure:Paragraph xmi:id="1455" sofa="1792" begin="7655" end="7680" wasGeneratedBy="122" rhetorical="par_23"/>
    <structure:Paragraph xmi:id="1462" sofa="1792" begin="7681" end="7697" wasGeneratedBy="122" rhetorical="par_24"/>
    <structure:Paragraph xmi:id="1469" sofa="1792" begin="7698" end="7722" wasGeneratedBy="122" rhetorical="par_25"/>
    <structure:Paragraph xmi:id="1476" sofa="1792" begin="7723" end="7776" wasGeneratedBy="122" rhetorical="par_26"/>
    <structure:Paragraph xmi:id="1483" sofa="1792" begin="7777" end="7828" wasGeneratedBy="122" rhetorical="par_27"/>
    <structure:Paragraph xmi:id="1490" sofa="1792" begin="7829" end="7892" wasGeneratedBy="122" rhetorical="par_28"/>
    <structure:Paragraph xmi:id="1497" sofa="1792" begin="7893" end="7953" wasGeneratedBy="122" rhetorical="par_29"/>
    <structure:Paragraph xmi:id="1504" sofa="1792" begin="7955" end="7970" wasGeneratedBy="122" rhetorical="par_30"/>
    <structure:Paragraph xmi:id="1511" sofa="1792" begin="7971" end="8139" wasGeneratedBy="122" rhetorical="par_31"/>
    <structure:Paragraph xmi:id="1518" sofa="1792" begin="8141" end="8163" wasGeneratedBy="122" rhetorical="par_32"/>
    <structure:Paragraph xmi:id="1525" sofa="1792" begin="8164" end="8287" wasGeneratedBy="122" rhetorical="par_33"/>
    <structure:Paragraph xmi:id="1532" sofa="1792" begin="8288" end="8476" wasGeneratedBy="122" rhetorical="par_34"/>
    <structure:Paragraph xmi:id="1539" sofa="1792" begin="8477" end="8660" wasGeneratedBy="122" rhetorical="par_35"/>
    <structure:Paragraph xmi:id="1546" sofa="1792" begin="8663" end="8680" wasGeneratedBy="122" rhetorical="par_36"/>
    <structure:Paragraph xmi:id="1553" sofa="1792" begin="8681" end="8791" wasGeneratedBy="122" rhetorical="par_37"/>
    <structure:Paragraph xmi:id="1560" sofa="1792" begin="8792" end="8833" wasGeneratedBy="122" rhetorical="par_38"/>
    <structure:Paragraph xmi:id="1567" sofa="1792" begin="8835" end="8853" wasGeneratedBy="122" rhetorical="par_39"/>
    <structure:Paragraph xmi:id="1574" sofa="1792" begin="8854" end="9003" wasGeneratedBy="122" rhetorical="par_40"/>
    <structure:Paragraph xmi:id="1581" sofa="1792" begin="9004" end="9147" wasGeneratedBy="122" rhetorical="par_41"/>
    <structure:Paragraph xmi:id="1588" sofa="1792" begin="9148" end="9304" wasGeneratedBy="122" rhetorical="par_42"/>
    <structure:Paragraph xmi:id="1595" sofa="1792" begin="9305" end="9480" wasGeneratedBy="122" rhetorical="par_43"/>
    <structure:Paragraph xmi:id="1602" sofa="1792" begin="9481" end="9641" wasGeneratedBy="122" rhetorical="par_44"/>
    <structure:Paragraph xmi:id="1609" sofa="1792" begin="9642" end="9805" wasGeneratedBy="122" rhetorical="par_45"/>
    <structure:Paragraph xmi:id="1616" sofa="1792" begin="9808" end="9829" wasGeneratedBy="122" rhetorical="par_46"/>
    <structure:Paragraph xmi:id="1623" sofa="1792" begin="9830" end="9849" wasGeneratedBy="122" rhetorical="par_47"/>
    <structure:Paragraph xmi:id="1630" sofa="1792" begin="9850" end="9891" wasGeneratedBy="122" rhetorical="par_48"/>
    <structure:Paragraph xmi:id="1637" sofa="1792" begin="9892" end="9974" wasGeneratedBy="122" rhetorical="par_49"/>
    <structure:Paragraph xmi:id="1644" sofa="1792" begin="9975" end="10019" wasGeneratedBy="122" rhetorical="par_50"/>
    <structure:Paragraph xmi:id="1651" sofa="1792" begin="10020" end="10066" wasGeneratedBy="122" rhetorical="par_51"/>
    <structure:Paragraph xmi:id="1658" sofa="1792" begin="10067" end="10111" wasGeneratedBy="122" rhetorical="par_52"/>
    <structure:Paragraph xmi:id="1665" sofa="1792" begin="10112" end="10158" wasGeneratedBy="122" rhetorical="par_53"/>
    <structure:Paragraph xmi:id="1672" sofa="1792" begin="10159" end="10205" wasGeneratedBy="122" rhetorical="par_54"/>
    <structure:Paragraph xmi:id="1679" sofa="1792" begin="10206" end="10249" wasGeneratedBy="122" rhetorical="par_55"/>
    <structure:Paragraph xmi:id="1686" sofa="1792" begin="10252" end="10274" wasGeneratedBy="122" rhetorical="par_56"/>
    <structure:Paragraph xmi:id="1693" sofa="1792" begin="10275" end="10290" wasGeneratedBy="122" rhetorical="par_57"/>
    <meta2:TableOfContents xmi:id="1700" sofa="1792" begin="10289" end="10290" wasGeneratedBy="122" outlines="430 439 565 448 457 574 583 466 475 484 493 592 502 511 520 529 538 601 610 547 556 619 628 637"/>
    <tcas:DocumentAnnotation xmi:id="1780" sofa="1799" begin="0" end="6581" language="x-unspecified"/>
    <cas:Sofa xmi:id="1785" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="Overview:&#9;&#10;Brief Title:&#9;Minocycline in Patients With Alzheimer's Disease.&#10;Official Title:&#9;MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy.&#10;NCT-ID:&#9;NCT01463384.&#10;Start Date:&#9;September 2011.&#10;Completion Date:&#9;October 2012.&#10;First Received Date:&#9;October 25, 2011.&#10;Last Updated:&#9;September 23, 2014.&#10;Verification Date:&#9;September 2014.&#10;Authority:&#9;United States: Institutional Review Board.&#10;Condition:&#9;Mild Cognitive Impairment;;Alzheimer's Disease.&#10;Keyword:&#9;Magnetic Resonance Imaging;;Magnetic Resonance Spectroscopy;;Neuroinflammation;;Mild Cognitive Impairment;;Alzheimer's Disease;;Minocycline.&#10;URL:&#9;http://clinicaltrials.gov/show/NCT01463384.&#10;&#10;Brief Summary:&#9;Cognitively normal individuals, patients with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) will undergo clinical screening, neuropsychological tests, blood and urine analyses, quantitative magnetic resonance imaging (MRI) and proton (1H ) and carbon 13 (13C) magnetic resonance spectroscopy (MRS). Each individual will receive minocycline oral administration for 4 weeks initially, after which MRI, MRS and neuropsychological results will be recorded. If no adverse side effects occur, subjects will continue minocycline administration for an additional 5 months.&#10;&#10;Detailed Description:&#9;In the course of on-going trials of novel MRI procedures for Neurological Diagnosis, the investigators have established non-invasive BIOMARKERS (Note: Biomarkers are objective Laboratory tests used in, but not replacing Clinical diagnostic criteria of any disease,in this case age-related dementia of the Alzheimer type and its pre-clinical forms including Mild Cognitive Impairment - MCI) which significantly assist in the Diagnosis of Alzheimer's Disease. MRS, rather like blood tests which are applied for screening and exclusion of medical disorders, provides a pattern of brain chemicals from which this and many other diagnoses have become available (see: Magnetic Resonance Spectroscopy in Neurological Diagnosis: E.R Danielsen and B.D. Ross, Marcel Dekker New York, 1999). Diagnosis of Alzheimer's Disease has hitherto been exclusively a clinical diagnosis, made on the basis of non-specific tests by the treating physician/neurologist. Furthermore, treatments have been of limited efficacy so that the pressure for conclusive diagnosis or an objective characterization of disease progression (or better, regression) has not been a priority. This conservative approach to Alzheimer's Disease changed in 2010 with the Report of National Institutes of Aging. First: The failures of treatment have been ascribed to introduction only in patients with advanced disease (&quot;dementia&quot;). Second: A preliminary form of AD, known as pre-clinical or Mild Cognitive Impairment, has been recognized, distinct from, and generally earlier in the disease course. Third: A new set of diagnostic criteria, which include objective 'biomarkers', from cerebrospinal fluid, genetic and imaging analyzes, has been accepted by the Expert Panel. Finally, Clinical trials of existing and new drugs for Alzheimer's Disease are expected to yield better results if initiated earlier - in the pre-clinical phase - and the outcomes evaluated by the earlier changes in an approved panel of biomarkers.&#10;&#10;Criteria:&#9;Inclusion Criteria.&#10; - Cognitively normal elderly subjects between the ages of 55-90 and patients aged 55 - 90 years who have mild cognitive impairment (MCI) or clinically defined Alzheimer's disease. Exclusion Criteria.&#10; - Any person with medical devices such as cardiac pacemakers/defibrillators or neuro-implants as they are contra-indications for MRI/MRS exam.&#10; - Since the effects of MRI are unknown to the fetus or unborn child, any person who is or may be pregnant will be excluded from the study.&#10; - History of known allergy or intolerance to minocycline or any other tetracycline - Impaired renal function (plasma Creatinine) or blood urea nitrogen (BUN) levels exceeds twice normal upper limit which can result in higher serum levels of tetracycline, azotemia, hyperphosphatemia and acidosis.&#10;&#10;Further Study Details:&#9;&#10;OverallStatus:&#9;Completed.&#10;Phase:&#9;Phase 2.&#10;Study Type:&#9;Interventional.&#10;Healthy Volunteer:&#9;Accepts Healthy Volunteers.&#10;Enrollment:&#9;13.&#10;Gender:&#9;Both.&#10;Minimum Age:&#9;55 Years.&#10;Maximum Age:&#9;90 Years.&#10;&#10;Other ID's:&#9;Secondary ID: No information,Org Study ID: LKW-AB34.&#10;PubMedID:&#9;No information.&#10;&#10;Design Information:&#10;&#9;Design Name:  Endpoint Classification,Design Value: Efficacy Study .&#10;Design Name:  Intervention Model,Design Value: Single Group Assignment .&#10;Design Name:  Masking,Design Value: Open Label .&#10;Design Name:  Primary Purpose,Design Value: Treatment.&#10;&#10;&#10;Intervention Information:&#10;&#9;Intervention Type: Drug,Intervention Name: Minocycline,Intervention Description: 50mg, twice daily for 6 months.&#10;&#10;Outcome Information:&#10;Outcome Details:&#10;&#9;Outcome Type: Primary.&#10;Outcome Title: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).&#10;Time Frame: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged).&#10;Outcome Description: RBANS is a brief neurocognitive battery with four alternate forms, measuring immediate and delayed memory, attention, language, and visuospatial skills. RBANS was developed as a stand-alone ???core??? battery for the detection and neurocognitive characterization of dementia and as a brief neurocognitive battery for the detection and tracking of neurocognitive deficits in a variety of disorders. (Reference: http://rbans.com/) Qualitative Description of Index Scores: Index Score Classification 130 and above Very Superior 120-129 Superior 110-119 High Average 90-109 Average 80-89 Low Average 70-79 Borderline 69 and below Extremely Low Psychometric range for RBANS: AD 0 - 77 MCI 78 - 99 Normal &gt; 100 Range of scores: Minimum = 0, Maximum = 130 Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration. &#10;&#10;Outcome Type: Primary.&#10;Outcome Title: Hippocampal Volumes Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC)..&#10;Time Frame: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged).&#10;Outcome Description: Using magnetic resonance images acquired, hippocampal volume was measured monthly for 6 months. Normal range for hippocampal volume in aged-matched controls is 6.6 - 8.8 cm^3. Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration. &#10;&#10;Outcome Type: Primary.&#10;Outcome Title: Biomarker NAA/mI Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC).&#10;Time Frame: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged).&#10;Outcome Description: It has been demonstrated in numerous studies over the past decade that magnetic resonance spectroscopy (MRS) can be used for the diagnosis of Alzheimer???s disease. By measuring an area within the posterior cingulate gyrus, one can obtain a biochemical signature of that region in AD whereby NAA is reduced and mI is increased. These two biomarkers, N-acetylaspartate (NAA, a neuronal marker) and myo-inositol (mI, a glial marker) were quantified and then used to calculate NAA/mI (an index currently widely used for AD and MCI diagnosis). Scale of MRS biomarkers for aged-matched controls: NAA = 1.43, mI = 0.60, NAA/mI = 2.38. Any value lower than NAA/mI of 2.38 are considered not normal. Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration.&#10;&#10;&#10;Outcome Analysis Details:&#10;&#9;No information.&#10;Outcome Measure Details:&#10;&#9;Outcome Units of Measure: Ratio,Measure Type: Mean .&#10;Outcome Units of Measure: cm^3,Measure Type: Mean .&#10;Outcome Units of Measure: units on a scale,Measure Type: Mean .&#10;Outcome Units of Measure: participants,Measure Type: Number.&#10;&#10;Outcome Values:&#10;&#9;1, 8, 4, 32.5, 32.9, 81, 58.7, 63.8, 106, 108.4, 123.6, 49, 5.49, 5.42, 4.94, 6.35, 6.30, 7.60, 6.98, 6.92, 6.82, 2.44, 2.47, 1.69, 1.78, 1.84, 1.87, 1.80, 2.08, 2.42.&#10;&#10;Study Outcome Details:&#10;&#9;Study Outcome Type:  primary outcome,Measure: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) .&#10;Study Outcome Type:  primary outcome,Measure: Hippocampal Volumes Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC). .&#10;Study Outcome Type:  primary outcome,Measure: Biomarker NAA/mI Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC).&#10;&#10;&#10;Location Details:&#10;Facility Details:&#9;City: Pasadena,Country: United States,Facility Name: Huntington Medical Research Institutes.&#10;Facility Contact Details:&#9;No information.&#10;&#10;Arm Group Details:&#10;&#9;Arm Group Label:  Minocycline,Arm Group Type: Active Comparator,Arm Group DEscription: Subjects will be administered 50mg minocycline twice daily. .&#10;Arm Group Label:  Minocycline,Arm Group Type: Baseline,Arm Group DEscription: Subjects administered 50mg minocycline twice daily for 6 months .&#10;Arm Group Label:  Minocycline,Arm Group Type: Participant Flow,Arm Group DEscription: Subjects were administered 50mg minocycline twice daily for 6 months .&#10;Arm Group Label:  Minocycline MCI,Arm Group Type: Results Outcome,Arm Group DEscription: Mild cognitively impaired subject who was administered 50mg minocycline twice daily. .&#10;Arm Group Label:  Minocycline AD,Arm Group Type: Results Outcome,Arm Group DEscription: Alzheimer subjects who were administered 50mg minocycline twice daily. .&#10;Arm Group Label:  Minocycline NC,Arm Group Type: Results Outcome,Arm Group DEscription: Normal control subjects who were administered 50mg minocycline twice daily.&#10;&#10;&#10;Baseline Information:&#10;Baseline ID:&#9;13745.&#10;Baseline Measure Details:&#9;No information.&#10;Baseline Measure Cateogary Details:&#9;Cateogary Title:  Female,Baseline Value: 308 .&#10;Cateogary Title:  Male,Baseline Value: 433 .&#10;Cateogary Title:  Female,Baseline Value: 178 .&#10;Cateogary Title:  Male,Baseline Value: 191 .&#10;Cateogary Title:  Female,Baseline Value: 190 .&#10;Cateogary Title:  Female,Baseline Value: 676 .&#10;Cateogary Title:  Male,Baseline Value: 815.&#10;&#10;&#10;Reference Information:&#10;&#9;No information&#10;"/>
    <cas:Sofa xmi:id="1792" sofaNum="2" sofaID="DocumentView" mimeType="text" sofaString="Overview:&#9;&#10;Brief Title:&#9;Minocycline in Patients With Alzheimer's Disease.&#10;Official Title:&#9;MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy.&#10;NCT-ID:&#9;NCT01463384.&#10;Start Date:&#9;September 2011.&#10;Completion Date:&#9;October 2012.&#10;First Received Date:&#9;October 25, 2011.&#10;Last Updated:&#9;September 23, 2014.&#10;Verification Date:&#9;September 2014.&#10;Authority:&#9;United States: Institutional Review Board.&#10;Condition:&#9;Mild Cognitive Impairment;;Alzheimer's Disease.&#10;Keyword:&#9;Magnetic Resonance Imaging;;Magnetic Resonance Spectroscopy;;Neuroinflammation;;Mild Cognitive Impairment;;Alzheimer's Disease;;Minocycline.&#10;URL:&#9;http://clinicaltrials.gov/show/NCT01463384.&#10;&#10;Brief Summary:&#9;Cognitively normal individuals, patients with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) will undergo clinical screening, neuropsychological tests, blood and urine analyses, quantitative magnetic resonance imaging (MRI) and proton (1H ) and carbon 13 (13C) magnetic resonance spectroscopy (MRS). Each individual will receive minocycline oral administration for 4 weeks initially, after which MRI, MRS and neuropsychological results will be recorded. If no adverse side effects occur, subjects will continue minocycline administration for an additional 5 months.&#10;&#10;Detailed Description:&#9;In the course of on-going trials of novel MRI procedures for Neurological Diagnosis, the investigators have established non-invasive BIOMARKERS (Note: Biomarkers are objective Laboratory tests used in, but not replacing Clinical diagnostic criteria of any disease,in this case age-related dementia of the Alzheimer type and its pre-clinical forms including Mild Cognitive Impairment - MCI) which significantly assist in the Diagnosis of Alzheimer's Disease. MRS, rather like blood tests which are applied for screening and exclusion of medical disorders, provides a pattern of brain chemicals from which this and many other diagnoses have become available (see: Magnetic Resonance Spectroscopy in Neurological Diagnosis: E.R Danielsen and B.D. Ross, Marcel Dekker New York, 1999). Diagnosis of Alzheimer's Disease has hitherto been exclusively a clinical diagnosis, made on the basis of non-specific tests by the treating physician/neurologist. Furthermore, treatments have been of limited efficacy so that the pressure for conclusive diagnosis or an objective characterization of disease progression (or better, regression) has not been a priority. This conservative approach to Alzheimer's Disease changed in 2010 with the Report of National Institutes of Aging. First: The failures of treatment have been ascribed to introduction only in patients with advanced disease (&quot;dementia&quot;). Second: A preliminary form of AD, known as pre-clinical or Mild Cognitive Impairment, has been recognized, distinct from, and generally earlier in the disease course. Third: A new set of diagnostic criteria, which include objective 'biomarkers', from cerebrospinal fluid, genetic and imaging analyzes, has been accepted by the Expert Panel. Finally, Clinical trials of existing and new drugs for Alzheimer's Disease are expected to yield better results if initiated earlier - in the pre-clinical phase - and the outcomes evaluated by the earlier changes in an approved panel of biomarkers.&#10;&#10;Criteria:&#9;Inclusion Criteria.&#10; - Cognitively normal elderly subjects between the ages of 55-90 and patients aged 55 - 90 years who have mild cognitive impairment (MCI) or clinically defined Alzheimer's disease. Exclusion Criteria.&#10; - Any person with medical devices such as cardiac pacemakers/defibrillators or neuro-implants as they are contra-indications for MRI/MRS exam.&#10; - Since the effects of MRI are unknown to the fetus or unborn child, any person who is or may be pregnant will be excluded from the study.&#10; - History of known allergy or intolerance to minocycline or any other tetracycline - Impaired renal function (plasma Creatinine) or blood urea nitrogen (BUN) levels exceeds twice normal upper limit which can result in higher serum levels of tetracycline, azotemia, hyperphosphatemia and acidosis.&#10;&#10;Further Study Details:&#9;&#10;OverallStatus:&#9;Completed.&#10;Phase:&#9;Phase 2.&#10;Study Type:&#9;Interventional.&#10;Healthy Volunteer:&#9;Accepts Healthy Volunteers.&#10;Enrollment:&#9;13.&#10;Gender:&#9;Both.&#10;Minimum Age:&#9;55 Years.&#10;Maximum Age:&#9;90 Years.&#10;&#10;Other ID's:&#9;Secondary ID: No information,Org Study ID: LKW-AB34.&#10;PubMedID:&#9;No information.&#10;&#10;Design Information:&#10;&#9;Design Name:  Endpoint Classification,Design Value: Efficacy Study .&#10;Design Name:  Intervention Model,Design Value: Single Group Assignment .&#10;Design Name:  Masking,Design Value: Open Label .&#10;Design Name:  Primary Purpose,Design Value: Treatment.&#10;&#10;&#10;Intervention Information:&#10;&#9;Intervention Type: Drug,Intervention Name: Minocycline,Intervention Description: 50mg, twice daily for 6 months.&#10;&#10;Outcome Information:&#10;Outcome Details:&#10;&#9;Outcome Type: Primary.&#10;Outcome Title: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).&#10;Time Frame: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged).&#10;Outcome Description: RBANS is a brief neurocognitive battery with four alternate forms, measuring immediate and delayed memory, attention, language, and visuospatial skills. RBANS was developed as a stand-alone ???core??? battery for the detection and neurocognitive characterization of dementia and as a brief neurocognitive battery for the detection and tracking of neurocognitive deficits in a variety of disorders. (Reference: http://rbans.com/) Qualitative Description of Index Scores: Index Score Classification 130 and above Very Superior 120-129 Superior 110-119 High Average 90-109 Average 80-89 Low Average 70-79 Borderline 69 and below Extremely Low Psychometric range for RBANS: AD 0 - 77 MCI 78 - 99 Normal &gt; 100 Range of scores: Minimum = 0, Maximum = 130 Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration. &#10;&#10;Outcome Type: Primary.&#10;Outcome Title: Hippocampal Volumes Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC)..&#10;Time Frame: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged).&#10;Outcome Description: Using magnetic resonance images acquired, hippocampal volume was measured monthly for 6 months. Normal range for hippocampal volume in aged-matched controls is 6.6 - 8.8 cm^3. Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration. &#10;&#10;Outcome Type: Primary.&#10;Outcome Title: Biomarker NAA/mI Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC).&#10;Time Frame: Baseline values, 1-3 Months Values (averaged), 4-6 Months Values (averaged).&#10;Outcome Description: It has been demonstrated in numerous studies over the past decade that magnetic resonance spectroscopy (MRS) can be used for the diagnosis of Alzheimer???s disease. By measuring an area within the posterior cingulate gyrus, one can obtain a biochemical signature of that region in AD whereby NAA is reduced and mI is increased. These two biomarkers, N-acetylaspartate (NAA, a neuronal marker) and myo-inositol (mI, a glial marker) were quantified and then used to calculate NAA/mI (an index currently widely used for AD and MCI diagnosis). Scale of MRS biomarkers for aged-matched controls: NAA = 1.43, mI = 0.60, NAA/mI = 2.38. Any value lower than NAA/mI of 2.38 are considered not normal. Values are reported below for Baseline, averaged for 1-3 months, and averaged for 4-6 months during minocycline administration.&#10;&#10;&#10;Outcome Analysis Details:&#10;&#9;No information.&#10;Outcome Measure Details:&#10;&#9;Outcome Units of Measure: Ratio,Measure Type: Mean .&#10;Outcome Units of Measure: cm^3,Measure Type: Mean .&#10;Outcome Units of Measure: units on a scale,Measure Type: Mean .&#10;Outcome Units of Measure: participants,Measure Type: Number.&#10;&#10;Outcome Values:&#10;&#9;1, 8, 4, 32.5, 32.9, 81, 58.7, 63.8, 106, 108.4, 123.6, 49, 5.49, 5.42, 4.94, 6.35, 6.30, 7.60, 6.98, 6.92, 6.82, 2.44, 2.47, 1.69, 1.78, 1.84, 1.87, 1.80, 2.08, 2.42.&#10;&#10;Study Outcome Details:&#10;&#9;Study Outcome Type:  primary outcome,Measure: Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) .&#10;Study Outcome Type:  primary outcome,Measure: Hippocampal Volumes Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC). .&#10;Study Outcome Type:  primary outcome,Measure: Biomarker NAA/mI Measured in Three Groups: Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) and Normal, Age-matched Controls (NC).&#10;&#10;&#10;Location Details:&#10;Facility Details:&#9;City: Pasadena,Country: United States,Facility Name: Huntington Medical Research Institutes.&#10;Facility Contact Details:&#9;No information.&#10;&#10;Arm Group Details:&#10;&#9;Arm Group Label:  Minocycline,Arm Group Type: Active Comparator,Arm Group DEscription: Subjects will be administered 50mg minocycline twice daily. .&#10;Arm Group Label:  Minocycline,Arm Group Type: Baseline,Arm Group DEscription: Subjects administered 50mg minocycline twice daily for 6 months .&#10;Arm Group Label:  Minocycline,Arm Group Type: Participant Flow,Arm Group DEscription: Subjects were administered 50mg minocycline twice daily for 6 months .&#10;Arm Group Label:  Minocycline MCI,Arm Group Type: Results Outcome,Arm Group DEscription: Mild cognitively impaired subject who was administered 50mg minocycline twice daily. .&#10;Arm Group Label:  Minocycline AD,Arm Group Type: Results Outcome,Arm Group DEscription: Alzheimer subjects who were administered 50mg minocycline twice daily. .&#10;Arm Group Label:  Minocycline NC,Arm Group Type: Results Outcome,Arm Group DEscription: Normal control subjects who were administered 50mg minocycline twice daily.&#10;&#10;&#10;Baseline Information:&#10;Baseline ID:&#9;13745.&#10;Baseline Measure Details:&#9;No information.&#10;Baseline Measure Cateogary Details:&#9;Cateogary Title:  Female,Baseline Value: 308 .&#10;Cateogary Title:  Male,Baseline Value: 433 .&#10;Cateogary Title:  Female,Baseline Value: 178 .&#10;Cateogary Title:  Male,Baseline Value: 191 .&#10;Cateogary Title:  Female,Baseline Value: 190 .&#10;Cateogary Title:  Female,Baseline Value: 676 .&#10;Cateogary Title:  Male,Baseline Value: 815.&#10;&#10;&#10;Reference Information:&#10;&#9;No information&#10;"/>
    <cas:Sofa xmi:id="1799" sofaNum="3" sofaID="ContentView" mimeType="text" sofaString="Table of Contents:&#10;    Overview: Overview:&#9; ____________________________________________________ 0 &#10;    Brief Summary: Brief Summary:&#9; ________________________________________ 681 &#10;      DETAILS  ___________________________________________________________ 1275 &#10;    Detailed Description: Detailed Descri ________________________________ 1276 &#10;    Criteria: Criteria:&#9;Inclu ____________________________________________ 3275 &#10;      Inclusion Criteria. Inclusion Crite ________________________________ 3285 &#10;      Exclusion Criteria. Exclusion Crite ________________________________ 3486 &#10;    Further Study Details: Further Study D _______________________________ 4089 &#10;    Design Information: Design Informat __________________________________ 4399 &#10;    Intervention Information: Intervention In ____________________________ 4668 &#10;    Outcome Information: Outcome Informa _________________________________ 4809 &#10;      Outcome Details: Outcome Details ___________________________________ 4830 &#10;    Outcome Analysis Details: on. ________________________________________ 7649 &#10;    Outcome Measure Details: tion. _______________________________________ 7692 &#10;    Outcome Values: ber. _________________________________________________ 7949 &#10;    Study Outcome Details: .42. __________________________________________ 8135 &#10;    Location Details: C). ________________________________________________ 8657 &#10;      Facility Details: ails: ____________________________________________ 8675 &#10;      Facility Contact Details: utes. ____________________________________ 8786 &#10;    Arm Group Details: ion. ______________________________________________ 8829 &#10;    Baseline Information: ly. ____________________________________________ 9802 &#10;      Baseline ID: tion: _________________________________________________ 9824 &#10;      Baseline Measure Details: 3745. ____________________________________ 9844 &#10;      Baseline Measure Cateogary Details: tion. __________________________ 9886 &#10;&#10;    par_1: PubMedID:&#9;No in _______________________________________________ 4372 &#10;    par_2: Design Informat _______________________________________________ 4399 &#10;    par_3: &#9;Design Name:   _______________________________________________ 4419 &#10;    par_4: Design Name:  I _______________________________________________ 4489 &#10;    par_5: Design Name:  M _______________________________________________ 4562 &#10;    par_6: Design Name:  P _______________________________________________ 4611 &#10;    par_7: Intervention In _______________________________________________ 4668 &#10;    par_8: &#9;Intervention T _______________________________________________ 4694 &#10;    par_9: Outcome Informa _______________________________________________ 4809 &#10;    par_10: Outcome Details ______________________________________________ 4830 &#10;    par_11: &#9;Outcome Type:  ______________________________________________ 4847 &#10;    par_12: Outcome Title:  ______________________________________________ 4871 &#10;    par_13: Time Frame: Bas ______________________________________________ 4962 &#10;    par_14: Outcome Descrip ______________________________________________ 5051 &#10;    par_15: Outcome Type: P ______________________________________________ 5951 &#10;    par_16: Outcome Title:  ______________________________________________ 5974 &#10;    par_17: Time Frame: Bas ______________________________________________ 6131 &#10;    par_18: Outcome Descrip ______________________________________________ 6220 &#10;    par_19: Outcome Type: P ______________________________________________ 6547 &#10;    par_20: Outcome Title:  ______________________________________________ 6570 &#10;    par_21: Time Frame: Bas ______________________________________________ 6723 &#10;    par_22: Outcome Descrip ______________________________________________ 6812 &#10;    par_23: Outcome Analysi ______________________________________________ 7655 &#10;    par_24: &#9;No information ______________________________________________ 7681 &#10;    par_25: Outcome Measure ______________________________________________ 7698 &#10;    par_26: &#9;Outcome Units  ______________________________________________ 7723 &#10;    par_27: Outcome Units o ______________________________________________ 7777 &#10;    par_28: Outcome Units o ______________________________________________ 7829 &#10;    par_29: Outcome Units o ______________________________________________ 7893 &#10;    par_30: Outcome Values: ______________________________________________ 7955 &#10;    par_31: &#9;1, 8, 4, 32.5, ______________________________________________ 7971 &#10;    par_32: Study Outcome D ______________________________________________ 8141 &#10;    par_33: &#9;Study Outcome  ______________________________________________ 8164 &#10;    par_34: Study Outcome T ______________________________________________ 8288 &#10;    par_35: Study Outcome T ______________________________________________ 8477 &#10;    par_36: Location Detail ______________________________________________ 8663 &#10;    par_37: Facility Detail ______________________________________________ 8681 &#10;    par_38: Facility Contac ______________________________________________ 8792 &#10;    par_39: Arm Group Detai ______________________________________________ 8835 &#10;    par_40: &#9;Arm Group Labe ______________________________________________ 8854 &#10;    par_41: Arm Group Label ______________________________________________ 9004 &#10;    par_42: Arm Group Label ______________________________________________ 9148 &#10;    par_43: Arm Group Label ______________________________________________ 9305 &#10;    par_44: Arm Group Label ______________________________________________ 9481 &#10;    par_45: Arm Group Label ______________________________________________ 9642 &#10;    par_46: Baseline Inform ______________________________________________ 9808 &#10;    par_47: Baseline ID:&#9;13 ______________________________________________ 9830 &#10;    par_48: Baseline Measur ______________________________________________ 9850 &#10;    par_49: Baseline Measur ______________________________________________ 9892 &#10;    par_50: Cateogary Title ______________________________________________ 9975 &#10;    par_51: Cateogary Title _____________________________________________ 10020 &#10;    par_52: Cateogary Title _____________________________________________ 10067 &#10;    par_53: Cateogary Title _____________________________________________ 10112 &#10;    par_54: Cateogary Title _____________________________________________ 10159 &#10;    par_55: Cateogary Title _____________________________________________ 10206 &#10;    par_56: Reference Infor _____________________________________________ 10252 &#10;    par_57: &#9;No information _____________________________________________ 10275 &#10;"/>
    <meta:DateTime xmi:id="1806" day="28" month="5" year="2016" hour="18" minute="46" second="13"/>
    <meta:DateTime xmi:id="1813" day="28" month="5" year="2016" hour="19" minute="4" second="32"/>
    <meta:Parameter xmi:id="1820" key="event" value="ExtractHeader ExtractFrontMatter" wasGeneratedBy="22"/>
    <meta:DateTime xmi:id="1824" day="28" month="5" year="2016" hour="18" minute="46" second="12"/>
    <meta:DateTime xmi:id="1831" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1838" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1845" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:Parameter xmi:id="1852" key="license" value="" wasGeneratedBy="56"/>
    <meta:Parameter xmi:id="1856" key="recipients" value="" wasGeneratedBy="56"/>
    <meta:DateTime xmi:id="1860" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1867" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1874" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1881" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1888" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1895" day="28" month="5" year="2016" hour="19" minute="4" second="31"/>
    <meta:DateTime xmi:id="1902" day="28" month="5" year="2016" hour="19" minute="4" second="32"/>
    <meta:DateTime xmi:id="1909" day="28" month="5" year="2016" hour="19" minute="4" second="32"/>
    <meta:DateTime xmi:id="1916" day="28" month="5" year="2016" hour="19" minute="4" second="32"/>
    <meta:DateTime xmi:id="1923" day="28" month="5" year="2016" hour="19" minute="4" second="32"/>
    <meta:Person xmi:id="1930" surname="" forename=""/>
    <meta:Date xmi:id="1935" day="25" month="10" year="2011"/>
    <meta:Concept xmi:id="1939" prefLabel="1945" identifier="NCT01463384" identifierSource="clinicaltrials.gov"/>
    <meta:Label xmi:id="1945" value="ctgov:NCT01463384"/>
    <cas:View sofa="1785" members="1 6 11 16 18 20 22 39 56 79 94 107 122 132 147 151 155 159 163 167 171 175 179 183 187 191 195 199 203 207 211 215 219 223 227 231 235 239 243 247 251 255 259 263 267 271 275 279 283 287 291 295 299 303 307 311 315 319 323 327 331 335 339 343 347 351 355 359 363 367 371 376 392"/>
    <cas:View sofa="1792" members="411 416 424 430 439 448 457 466 475 484 493 502 511 520 529 538 547 556 565 574 583 592 601 610 619 628 637 646 657 664 671 678 685 692 699 706 713 720 727 734 741 748 755 762 769 776 783 790 797 804 811 818 825 832 839 846 853 860 867 874 881 888 895 902 909 916 923 930 937 944 951 958 965 972 979 986 993 1000 1007 1014 1021 1028 1035 1042 1049 1056 1063 1070 1077 1084 1091 1098 1105 1112 1119 1126 1133 1140 1147 1154 1161 1168 1175 1182 1189 1196 1203 1210 1217 1224 1231 1238 1245 1252 1259 1266 1273 1280 1287 1294 1301 1308 1315 1322 1329 1336 1343 1350 1357 1364 1371 1378 1385 1392 1399 1406 1413 1420 1427 1434 1441 1448 1455 1462 1469 1476 1483 1490 1497 1504 1511 1518 1525 1532 1539 1546 1553 1560 1567 1574 1581 1588 1595 1602 1609 1616 1623 1630 1637 1644 1651 1658 1665 1672 1679 1686 1693 1700"/>
    <cas:View sofa="1799" members="1780"/>
</xmi:XMI>
